Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab for COVID-19 pneumonia
ChiCTR2000029765Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Feb 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of tocilizumab in coronavirus pneumonia (2 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoint: Cure rate. Started Feb 2020; status: recruiting.
02
Drugs
tocilizumab
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on ChiCTR2000029765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029765.